Qlucore AB Share Price

Equities

QCORE

SE0016829824

Software

Delayed Nasdaq Stockholm 15:25:37 29/04/2024 BST 5-day change 1st Jan Change
7.7 SEK -4.94% Intraday chart for Qlucore AB -8.33% +0.65%

Financials

Sales 2022 22.5M 2.06M 164M Sales 2023 31.45M 2.88M 230M Capitalization 53.98M 4.94M 394M
Net income 2022 -11M -1.01M -80.34M Net income 2023 -15M -1.37M -110M EV / Sales 2022 0.95 x
Net cash position 2022 92.64M 8.47M 677M Net cash position 2023 65.27M 5.97M 477M EV / Sales 2023 -0.36 x
P/E ratio 2022
-9.77 x
P/E ratio 2023
-3.39 x
Employees 22
Yield 2022 *
-
Yield 2023
-
Free-Float 45.57%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.94%
1 week-8.33%
Current month-10.47%
1 month-10.98%
3 months-2.53%
6 months-21.83%
Current year+0.65%
More quotes
1 week
7.70
Extreme 7.7
8.20
1 month
7.70
Extreme 7.7
9.05
Current year
6.80
Extreme 6.8
11.50
1 year
5.75
Extreme 5.75
13.50
3 years
5.75
Extreme 5.75
58.00
5 years
5.75
Extreme 5.75
58.00
10 years
5.75
Extreme 5.75
58.00
More quotes
Managers TitleAgeSince
Founder 56 04/12/06
Director of Finance/CFO - 31/01/22
Chief Tech/Sci/R&D Officer - 06/02/22
Members of the board TitleAgeSince
Director/Board Member 65 31/12/18
Chairman 70 31/12/08
Founder 66 04/12/06
More insiders
Date Price Change Volume
29/04/24 7.7 -4.94% 8 298
26/04/24 8.1 0.00% 500
25/04/24 8.1 -0.61% 600
24/04/24 8.15 -2.98% 3,241
22/04/24 8.4 -0.59% 161

Delayed Quote Nasdaq Stockholm, April 29, 2024 at 03:25 pm

More quotes
Qlucore AB is a Sweden-based provider of new generation of intuitive bioinformatics software for research and precision and companion diagnostics. Its mission is to make it easier to analyze the vast amounts of complex data generated by innovations in genomics and proteomics. This is done by providing visualization-based analysis data tools for bioinformatics for research and precision diagnostics. The tools are so easy to use that researchers, technicians and doctors can easily interpret and explore their data sets. Qlucore Diagnostics software is a platform for multi-omics companion and precision diagnostics. AI-driven, disease-specific machine learning-based classification models are combined with patient-friendly visualizations in an easy-to-use and cost-effective software solution that integrates with a wide range of data-generating technologies and instruments. Qlucore was founded in 2007 by researchers at the departments of mathematics and clinical genetics at Lund University.
Calendar
More about the company